Despite indications that the CXCL10/CXCR3 axis is involved in the development of hypersensitivity pneumonitis (HP), nothing is known about the therapeutic benefits of small molecule suppression of the pair components. This evidence concerns the gene CXCL10 and hypersensitivity pneumonitis.